BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rowan JA, Rush EC, Plank LD, Lu J, Obolonkin V, Coat S, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care 2018;6:e000456. [PMID: 29682291 DOI: 10.1136/bmjdrc-2017-000456] [Cited by in Crossref: 129] [Cited by in F6Publishing: 135] [Article Influence: 25.8] [Reference Citation Analysis]
Number Citing Articles
1 Hummel M, Füchtenbusch M, Battefeld W, Bührer C, Groten T, Haak T, Kainer F, Kautzky-Willer A, Lechner A, Meissner T, Nagel-Reuper C, Schäfer-Graf U, Siegmund T. Diabetes and Pregnancy. Exp Clin Endocrinol Diabetes 2023. [PMID: 36626920 DOI: 10.1055/a-1946-3648] [Reference Citation Analysis]
2 Newman C, Dunne F, Egan A. Drug interactions for women with diabetes and obesity during pregnancy. Handbook of Obesity in Obstetrics and Gynecology 2023. [DOI: 10.1016/b978-0-323-89904-8.00012-3] [Reference Citation Analysis]
3 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Jeffrie Seley J, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S254-66. [PMID: 36507645 DOI: 10.2337/dc23-S015] [Reference Citation Analysis]
4 Tirkey R, Paul P, Kingsbury B, Yenuberi H, Benjamin S, Rathore S, Manimegalai B, Belavendra A, Mathews J. The study of offspring and mothers with gestational diabetes treated with metformin or glibenclamide in a randomized controlled trial after 9 years. Curr Med Issues 2023;21:50. [DOI: 10.4103/cmi.cmi_95_22] [Reference Citation Analysis]
5 Sorice GP, Caporusso M, Cignarelli A, Perrini S, Natalicchio A, Giorgino F. Metformin use in pregnancy: efficacy, safety, and potential benefits. J Endocrinol Invest 2022. [PMID: 36586087 DOI: 10.1007/s40618-022-01991-4] [Reference Citation Analysis]
6 Hummel M, Füchtenbusch M, Battefeld W, Bührer C, Groten T, Haak T, Kainer F, Kautzky-willer A, Lechner A, Meissner T, Nagel-reuper C, Schäfer-graf U, Siegmund T. Diabetes und Schwangerschaft. Diabetologie 2022. [DOI: 10.1007/s11428-022-00988-0] [Reference Citation Analysis]
7 Du Y, Zhu YJ, Zhou YX, Ding J, Liu JY. Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study. Mol Biomed 2022;3:41. [PMID: 36484892 DOI: 10.1186/s43556-022-00108-w] [Reference Citation Analysis]
8 Hummel M, Füchtenbusch M, Battefeld W, Bührer C, Groten T, Haak T, Kainer F, Kautzky-willer A, Lechner A, Meissner T, Nagel-reuper C, Schäfer-graf U, Siegmund T. Diabetes und Schwangerschaft. Diabetes aktuell 2022;20:365-375. [DOI: 10.1055/a-1976-8965] [Reference Citation Analysis]
9 Paschou SA, Bletsa E, Papazisi M, Mili N, Kanouta F, Kassi GN, Psaltopoulou T, Goulis DG, Lambrinoudaki I. Screening and management of major endocrinopathies during pregnancy: an update. Endocrine 2022. [DOI: 10.1007/s12020-022-03237-y] [Reference Citation Analysis]
10 White ND. Drug-Induced Microbiome Changes: Considerations in Pregnancy. Am J Lifestyle Med 2023;17:50-3. [PMID: 36636397 DOI: 10.1177/15598276221130259] [Reference Citation Analysis]
11 Hummel M, Füchtenbusch M, Battefeld W, Bührer C, Groten T, Haak T, Kainer F, Kautzky-willer A, Lechner A, Meissner T, Nagel-reuper C, Schäfer-graf U, Siegmund T. Diabetes und Schwangerschaft. Diabetologie und Stoffwechsel 2022;17:S205-S214. [DOI: 10.1055/a-1901-0499] [Reference Citation Analysis]
12 Modzelewski R, Stefanowicz-rutkowska MM, Matuszewski W, Bandurska-stankiewicz EM. Gestational Diabetes Mellitus—Recent Literature Review. JCM 2022;11:5736. [DOI: 10.3390/jcm11195736] [Reference Citation Analysis]
13 Song L, Cui J, Hu S, Wang R, Li H, Sun B. Maternal Treatment with Metformin Persistently Ameliorates High-Fat Diet-Induced Metabolic Symptoms and Modulates Gut Microbiota in Rat Offspring. Nutrients 2022;14:3612. [DOI: 10.3390/nu14173612] [Reference Citation Analysis]
14 González Corona C, Parchem RJ. Maternal diabetes negatively impacts fetal health. Open Biol 2022;12:220135. [PMID: 36128718 DOI: 10.1098/rsob.220135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Seneviratne SN, Rajindrajith S. Fetal programming of obesity and type 2 diabetes. World J Diabetes 2022; 13(7): 482-497 [DOI: 10.4239/wjd.v13.i7.482] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Stupin JH. Kein erhöhtes Langzeitrisiko fürs Baby mit Metformin-Therapie versus Insulin. Info Diabetol 2022;16:22-23. [DOI: 10.1007/s15034-022-3839-9] [Reference Citation Analysis]
17 Schmitz K, Turnwald EM, Kretschmer T, Janoschek R, Bae-Gartz I, Voßbrecher K, Kammerer MD, Köninger A, Gellhaus A, Handwerk M, Wohlfarth M, Gründemann D, Hucklenbruch-Rother E, Dötsch J, Appel S. Metformin Prevents Key Mechanisms of Obesity-Related Complications in Visceral White Adipose Tissue of Obese Pregnant Mice. Nutrients 2022;14:2288. [PMID: 35684088 DOI: 10.3390/nu14112288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lin J, Yin R. Exposure to Endocrine-Disrupting Chemicals and Type 2 Diabetes Mellitus in Later Life. Expo Health. [DOI: 10.1007/s12403-022-00486-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Huhtala M, Nikkinen H, Paavilainen E, Niinikoski H, Vääräsmäki M, Loo BM, Rönnemaa T, Tertti K. Comparison of glucose metabolism and anthropometry in women with previous gestational diabetes treated with metformin vs. insulin: 9-year follow-up of two randomized trials. Acta Obstet Gynecol Scand 2022;101:514-23. [PMID: 35274295 DOI: 10.1111/aogs.14343] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H, Macdonald R, Hollenberg MD, Hill MA. Metformin: Is it a drug for all reasons and diseases? Metabolism 2022. [DOI: 10.1016/j.metabol.2022.155223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bastian B, Smithers LG, Davis W, Pape A, Francois ME. Metformin: A promising option for the management of gestational diabetes mellitus - Exploring the benefits, challenges and clinical needs in the current management of gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 2022. [PMID: 35362563 DOI: 10.1111/ajo.13513] [Reference Citation Analysis]
22 Notaro ALG, Neto FTL. The use of metformin in women with polycystic ovary syndrome: an updated review. J Assist Reprod Genet. [DOI: 10.1007/s10815-022-02429-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Fornes R, Simin J, Nguyen MH, Cruz G, Crisosto N, van der Schaaf M, Engstrand L, Brusselaers N. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol 2022;20. [DOI: 10.1186/s12958-022-00905-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
24 Zera CA, Seely EW. Controversies in Gestational Diabetes. touchREV Endocrinol 2021;17:102-7. [PMID: 35118455 DOI: 10.17925/EE.2021.17.2.102] [Reference Citation Analysis]
25 Schäfer-graf U, Reger-tan S. PCOS und Schwangerschaft. Gynäkologe 2022;55:85-89. [DOI: 10.1007/s00129-021-04894-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Lumsden RH, Pagidipati N. Management of cardiovascular risk factors during pregnancy. Heart. [DOI: 10.1136/heartjnl-2021-319606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Rotar IC, Stănică B, Petca A, Mureşan D. Metformin in the management of gestational diabetes. Obstetrica şi Ginecologia 2022;2:32. [DOI: 10.26416/obsgin.70.2.2022.6682] [Reference Citation Analysis]
28 Schoonejans JM, Blackmore HL, Ashmore TJ, Pantaleão LC, Pellegrini Pisani L, Dearden L, Tadross JA, Aiken CE, Fernandez-Twinn DS, Ozanne SE. Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring. Diabetologia 2022;65:2132-45. [PMID: 36112170 DOI: 10.1007/s00125-022-05789-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Brand KMG, Saarelainen L, Sonajalg J, Boutmy E, Foch C, Vääräsmäki M, Morin-Papunen L, Schlachter J, Hakkarainen KM, Korhonen P; CLUE Study Group. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. BMJ Open Diabetes Res Care 2022;10:e002363. [PMID: 34987051 DOI: 10.1136/bmjdrc-2021-002363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Chatzakis C, Sotiriadis A, Gerede A, Dinas K, Nicolaides KH. Fetal Complications. Comprehensive Clinical Approach to Diabetes During Pregnancy 2022. [DOI: 10.1007/978-3-030-89243-2_16] [Reference Citation Analysis]
31 Romeo GR, Silva PS, Cavallerano J. Diabetes Mellitus. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_294] [Reference Citation Analysis]
32 Suganthi K, Sarkar N. Blood glucose management in gestational diabetes: A clinician's review. Chron Diabetes Res Pract 2022;1:31. [DOI: 10.4103/cdrp.cdrp_2_21] [Reference Citation Analysis]
33 American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S232-43. [PMID: 34964864 DOI: 10.2337/dc22-S015] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 39.0] [Reference Citation Analysis]
34 Palatnik A, Harrison RK, Thakkar MY, Walker RJ, Egede LE. Correlates of Insulin Selection as a First-Line Pharmacological Treatment for Gestational Diabetes. Am J Perinatol 2022;39:8-15. [PMID: 34758497 DOI: 10.1055/s-0041-1739266] [Reference Citation Analysis]
35 Egan AM, Dunne FP. Managing Gestational Diabetes During and After Pregnancy. Clinical Dilemmas in Diabetes 2021. [DOI: 10.1002/9781119603207.ch6] [Reference Citation Analysis]
36 Quadir H. Current Therapeutic Use of Metformin During Pregnancy: Maternal Changes, Postnatal Effects and Safety. Cureus 2021;13:e18818. [PMID: 34804675 DOI: 10.7759/cureus.18818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Roy A, Sahoo J. Long-term effects of metformin use in gestational diabetes mellitus on offspring health. World J Diabetes 2021; 12(11): 1812-1817 [PMID: 34888009 DOI: 10.4239/wjd.v12.i11.1812] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Simmons R. Metformin in pregnancy: a re-examination of its safety. J Physiol 2021. [PMID: 34762307 DOI: 10.1113/JP282324] [Reference Citation Analysis]
39 Picón-César MJ, Molina-Vega M, Suárez-Arana M, González-Mesa E, Sola-Moyano AP, Roldan-López R, Romero-Narbona F, Olveira G, Tinahones FJ, González-Romero S. Metformin for gestational diabetes study: metformin vs insulin in gestational diabetes: glycemic control and obstetrical and perinatal outcomes: randomized prospective trial. Am J Obstet Gynecol 2021;225:517.e1-517.e17. [PMID: 33887240 DOI: 10.1016/j.ajog.2021.04.229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
40 Venkatesh KK, Chiang CW, Castillo WC, Battarbee AN, Donneyong M, Harper LM, Costantine M, Saade G, Werner EF, Boggess KA, Landon MB. Changing patterns in medication prescription for gestational diabetes during a time of guideline change in the USA: a cross-sectional study. BJOG 2021. [PMID: 34605130 DOI: 10.1111/1471-0528.16960] [Reference Citation Analysis]
41 Newman C, Dunne FP. Metformin for pregnancy and beyond: the pros and cons. Diabet Med 2021;:e14700. [PMID: 34569082 DOI: 10.1111/dme.14700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Schoonejans JM, Blackmore HL, Ashmore TJ, Aiken CE, Fernandez-Twinn DS, Ozanne SE. Maternal Metformin Intervention during Obese Glucose-Intolerant Pregnancy Affects Adiposity in Young Adult Mouse Offspring in a Sex-Specific Manner. Int J Mol Sci 2021;22:8104. [PMID: 34360870 DOI: 10.3390/ijms22158104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
43 Mirabelli M, Chiefari E, Tocci V, Greco E, Foti D, Brunetti A. Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options. Curr Opin Pharmacol 2021;60:1-10. [PMID: 34280703 DOI: 10.1016/j.coph.2021.06.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
44 Cheng D, Zhou X, Xu X. The Role of Metformin in Treating Preeclampsia. Maternal-Fetal Medicine 2021;3:203-7. [DOI: 10.1097/fm9.0000000000000086] [Reference Citation Analysis]
45 Huhtala MS, Rönnemaa T, Pellonperä O, Tertti K. Cord serum metabolome and birth weight in patients with gestational diabetes treated with metformin, insulin, or diet alone. BMJ Open Diabetes Res Care 2021;9:e002022. [PMID: 34059525 DOI: 10.1136/bmjdrc-2020-002022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Yang L, Lacey L, Whyte S, Quenby S, Denison FC, Dhaun N, Norman JE, Drake AJ, Reynolds RM. Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood. J Dev Orig Health Dis 2021;:1-5. [PMID: 34134812 DOI: 10.1017/S2040174421000301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Bedell S, Hutson J, de Vrijer B, Eastabrook G. Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions. Curr Vasc Pharmacol 2021;19:176-92. [PMID: 32543363 DOI: 10.2174/1570161118666200616144512] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
48 Tsakiridis I, Giouleka S, Mamopoulos A, Kourtis A, Athanasiadis A, Filopoulou D, Dagklis T. Diagnosis and Management of Gestational Diabetes Mellitus: An Overview of National and International Guidelines. Obstet Gynecol Surv 2021;76:367-81. [PMID: 34192341 DOI: 10.1097/OGX.0000000000000899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
49 Owen MD, Baker BC, Scott EM, Forbes K. Interaction between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies. Int J Mol Sci 2021;22:5759. [PMID: 34071182 DOI: 10.3390/ijms22115759] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
50 McElwain CJ, McCarthy FP, McCarthy CM. Gestational Diabetes Mellitus and Maternal Immune Dysregulation: What We Know So Far. Int J Mol Sci 2021;22:4261. [PMID: 33923959 DOI: 10.3390/ijms22084261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
51 Versace VL, Beks H, Wesley H, McNamara K, Hague W, Anjana RM, Mohan V, Khunti K, Dunbar JA. Metformin for Preventing Type 2 Diabetes Mellitus in Women with a Previous Diagnosis of Gestational Diabetes: A Narrative Review. Semin Reprod Med 2020;38:366-76. [PMID: 33860488 DOI: 10.1055/s-0041-1727203] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Rossiter C, Cheng H, Appleton J, Campbell KJ, Denney-Wilson E. Addressing obesity in the first 1000 days in high risk infants: Systematic review. Matern Child Nutr 2021;17:e13178. [PMID: 33780128 DOI: 10.1111/mcn.13178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
53 Van Dam JM, Goldsworthy MR, Hague WM, Coat S, Pitcher JB. Cortical Plasticity and Interneuron Recruitment in Adolescents Born to Women with Gestational Diabetes Mellitus. Brain Sci 2021;11:388. [PMID: 33808544 DOI: 10.3390/brainsci11030388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Drzewoski J, Hanefeld M. The Current and Potential Therapeutic Use of Metformin-The Good Old Drug. Pharmaceuticals (Basel) 2021;14:122. [PMID: 33562458 DOI: 10.3390/ph14020122] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
55 Zhang FF, Zhang Q, Wang YL, Wang FF, Hardiman PJ, Qu F. Intergenerational Influences between Maternal Polycystic Ovary Syndrome and Offspring: An Updated Overview. J Pediatr 2021;232:272-81. [PMID: 33482217 DOI: 10.1016/j.jpeds.2021.01.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Chu AHY, Godfrey KM. Gestational Diabetes Mellitus and Developmental Programming. Ann Nutr Metab 2020;76 Suppl 3:4-15. [PMID: 33465774 DOI: 10.1159/000509902] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
57 Shpakov AO. Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms. Pharmaceuticals (Basel) 2021;14:42. [PMID: 33429918 DOI: 10.3390/ph14010042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
58 Romeo GR, Silva PS, Cavallerano J. Diabetes Mellitus. Albert and Jakobiec's Principles and Practice of Ophthalmology 2021. [DOI: 10.1007/978-3-319-90495-5_294-1] [Reference Citation Analysis]
59 Ottanelli S, Simeone S, Serena C, Rambaldi MP, Zullino S, Mecacci F. Pregnancy Outcome and Metabolic Syndrome. ISGE Series 2021. [DOI: 10.1007/978-3-030-63650-0_13] [Reference Citation Analysis]
60 Dröge LA, Fischer T, Grab D, Grubert T, Hantschmann P, Henrich W, Kästner R, Kainer F, Kentenich C, Klockenbusch W, Lammert F, Louwen F, Mylonas I, von Steinburg SP, Schäfer-graf UM, Schleußner E, Schmitz R, Verlohren S. Maternale Erkrankungen in der Schwangerschaft. Facharztwissen Geburtsmedizin 2021. [DOI: 10.1016/b978-3-437-23753-9.00017-7] [Reference Citation Analysis]
61 Zhang Y, Liu X, Yang L, Zou L. Current Researches, Rationale, Plausibility, and Evidence Gaps on Metformin for the Management of Hypertensive Disorders of Pregnancy. Front Pharmacol 2020;11:596145. [PMID: 33381040 DOI: 10.3389/fphar.2020.596145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
62 Rudland VL, Price SAL, Hughes R, Barrett HL, Lagstrom J, Porter C, Britten FL, Glastras S, Fulcher I, Wein P, Simmons D, McIntyre HD, Callaway L. ADIPS 2020 guideline for pre-existing diabetes and pregnancy. Aust N Z J Obstet Gynaecol 2020;60:E18-52. [PMID: 33200400 DOI: 10.1111/ajo.13265] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
63 Garcia-Contreras C, Vazquez-Gomez M, Pesantez-Pacheco JL, Heras-Molina A, Encinas T, Astiz S, Gonzalez-Bulnes A. The Effects of Maternal Metformin Treatment on Late Prenatal and Early Postnatal Development of the Offspring Are Modulated by Sex. Pharmaceuticals (Basel) 2020;13:E363. [PMID: 33158193 DOI: 10.3390/ph13110363] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Rudland VL, Price SAL, Callaway L. ADIPS position paper on pre-existing diabetes and pregnancy. Aust N Z J Obstet Gynaecol 2020;60:831-9. [PMID: 33135798 DOI: 10.1111/ajo.13266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Feghali M, Atlass J, Abebe KZ, Comer D, Catov J, Caritis S, Arslanian S, Scifres C. Treatment of Gestational Diabetes Mellitus and Offspring Early Childhood Growth. J Clin Endocrinol Metab 2021;106:e1849-58. [PMID: 33057663 DOI: 10.1210/clinem/dgaa742] [Reference Citation Analysis]
66 Feig DS, Donovan LE, Zinman B, Sanchez JJ, Asztalos E, Ryan EA, Fantus IG, Hutton E, Armson AB, Lipscombe LL, Simmons D, Barrett JFR, Karanicolas PJ, Tobin S, McIntyre HD, Tian SY, Tomlinson G, Murphy KE; MiTy Collaborative Group. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2020;8:834-44. [PMID: 32946820 DOI: 10.1016/S2213-8587(20)30310-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
67 Paul P, Priyambada L, Abraham A, Manimegalai B, Paul TV, Princy S, Antonisamy B, Thomas N, Yenuberi H, Mathews JE. Follow‐up of offspring and mothers with gestational diabetes treated with metformin or glibenclamide: A randomized controlled trial. Int J Gynecol Obstet 2021;152:446-7. [DOI: 10.1002/ijgo.13380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Continuing Challenges in The Medical Management of Gestational Diabetes Mellitus. EMJ Diabet 2020. [DOI: 10.33590/emjdiabet/20-00003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 López-reyes A, Escobedo-aguirre F, Lugo-cruz M, Jaén-vento L, Macías-amezcua M. Efectos perinatales de la metformina en diabetes gestacional. Clínica e Investigación en Ginecología y Obstetricia 2021;48:100636. [DOI: 10.1016/j.gine.2020.09.002] [Reference Citation Analysis]
70 Benhalima K, Minschart C, Van Crombrugge P, Calewaert P, Verhaeghe J, Vandamme S, Theetaert K, Devlieger R, Pierssens L, Ryckeghem H, Dufraimont E, Vercammen C, Debie A, De Block C, Vandenberghe G, Van Imschoot S, Verstraete S, Buyse L, Wens J, Muyldermans J, Meskal A, De Spiegeleer S, Mathieu C. The 2019 Flemish consensus on screening for overt diabetes in early pregnancy and screening for gestational diabetes mellitus. Acta Clin Belg 2020;75:340-7. [PMID: 31259665 DOI: 10.1080/17843286.2019.1637389] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
71 Huhtala MS, Tertti K, Rönnemaa T. Serum lipids and their association with birth weight in metformin and insulin treated patients with gestational diabetes. Diabetes Res Clin Pract 2020;170:108456. [PMID: 32979417 DOI: 10.1016/j.diabres.2020.108456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
72 Lin SF, Chang SH, Kuo CF, Lin WT, Chiou MJ, Huang YT. Association of pregnancy outcomes in women with type 2 diabetes treated with metformin versus insulin when becoming pregnant. BMC Pregnancy Childbirth 2020;20:512. [PMID: 32887578 DOI: 10.1186/s12884-020-03207-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
73 Kislal S, Shook LL, Edlow AG. Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring. Prenat Diagn 2020;40:1109-25. [PMID: 32643194 DOI: 10.1002/pd.5784] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
74 Panagiotopoulou O, Syngelaki A, Georgiopoulos G, Simpson J, Akolekar R, Shehata H, Nicolaides K, Charakida M. Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring. Am J Obstet Gynecol 2020;223:246.e1-246.e10. [PMID: 32017923 DOI: 10.1016/j.ajog.2020.01.054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
75 Egan AM, Dow ML, Vella A. A Review of the Pathophysiology and Management of Diabetes in Pregnancy. Mayo Clin Proc 2020;95:2734-46. [PMID: 32736942 DOI: 10.1016/j.mayocp.2020.02.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
76 Huhtala MS, Tertti K, Juhila J, Sorsa T, Rönnemaa T. Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 - secondary analysis of a randomized controlled trial. BMC Pregnancy Childbirth 2020;20:401. [PMID: 32652973 DOI: 10.1186/s12884-020-03077-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
77 Murray SR, Reynolds RM. Short- and long-term outcomes of gestational diabetes and its treatment on fetal development. Prenat Diagn 2020;40:1085-91. [PMID: 32946125 DOI: 10.1002/pd.5768] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
78 Jorquera G, Echiburú B, Crisosto N, Sotomayor-Zárate R, Maliqueo M, Cruz G. Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function. Front Pharmacol 2020;11:653. [PMID: 32625081 DOI: 10.3389/fphar.2020.00653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
79 Griffith RJ, Alsweiler J, Moore AE, Brown S, Middleton P, Shepherd E, Crowther CA. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2020;6:CD012394. [PMID: 32526091 DOI: 10.1002/14651858.CD012394.pub3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 34] [Article Influence: 7.7] [Reference Citation Analysis]
80 Ma'ayeh M, Costantine MM. Prevention of preeclampsia. Semin Fetal Neonatal Med 2020;25:101123. [PMID: 32513597 DOI: 10.1016/j.siny.2020.101123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
81 Tarry-Adkins JL, Aiken CE, Ozanne SE. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis. PLoS Med 2020;17:e1003126. [PMID: 32442232 DOI: 10.1371/journal.pmed.1003126] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
82 Nayak G, Salian SR, Agarwal P, Suresh Poojary P, Rao A, Kumari S, Kalthur SG, Shreya AB, Mutalik S, Adiga SK, Kalthur G. Antidiabetic drug metformin affects the developmental competence of cleavage-stage embryos. J Assist Reprod Genet 2020;37:1227-38. [PMID: 32335799 DOI: 10.1007/s10815-020-01709-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
83 Echiburú B, Milagro F, Crisosto N, Pérez-Bravo F, Flores C, Arpón A, Salas-Pérez F, Recabarren SE, Sir-Petermann T, Maliqueo M. DNA methylation in promoter regions of genes involved in the reproductive and metabolic function of children born to women with PCOS. Epigenetics 2020;15:1178-94. [PMID: 32283997 DOI: 10.1080/15592294.2020.1754674] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
84 Lv Z, Guo Y. Metformin and Its Benefits for Various Diseases. Front Endocrinol (Lausanne) 2020;11:191. [PMID: 32425881 DOI: 10.3389/fendo.2020.00191] [Cited by in Crossref: 100] [Cited by in F6Publishing: 106] [Article Influence: 33.3] [Reference Citation Analysis]
85 Gonzalez CD, Alvariñas J, Bagnes MFG, Di Girolamo G. Metformin and Pregnancy Outcomes: Evidence Gaps and Unanswered Questions. Curr Clin Pharmacol 2019;14:54-60. [PMID: 30585549 DOI: 10.2174/1574884714666181224151116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Egan AM, Dunne FP. Optimal management of gestational diabetes. Br Med Bull 2019;131:97-108. [PMID: 31504226 DOI: 10.1093/bmb/ldz025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
87 Stewart ZA. Gestational diabetes. Obstetrics, Gynaecology & Reproductive Medicine 2020;30:79-83. [DOI: 10.1016/j.ogrm.2019.12.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
88 Ma'ayeh M, Rood KM, Kniss D, Costantine MM. Novel Interventions for the Prevention of Preeclampsia. Curr Hypertens Rep 2020;22:17. [PMID: 32052203 DOI: 10.1007/s11906-020-1026-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
89 Azzaroli F, Mazzella G, Marchesini G, Brodosi L, Petroni ML. Fatty liver in pregnancy: a narrative review of two distinct conditions. Expert Rev Gastroenterol Hepatol 2020;14:127-35. [PMID: 31928239 DOI: 10.1080/17474124.2020.1715210] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
90 Pancer J, Wu N, Mahmoud I, Dasgupta K. Pharmacological intervention for diabetes after pregnancy prevention in women with prior gestational diabetes: A scoping review. Diabetes Res Clin Pract 2020;160:107998. [PMID: 31911249 DOI: 10.1016/j.diabres.2020.107998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
91 Feng Y, Yang H. Metformin in Pregnancy with Diabetes—Opinions from Several Latest Guidelines. Maternal-Fetal Medicine 2020;2:10-1. [DOI: 10.1097/fm9.0000000000000036] [Reference Citation Analysis]
92 Oskovi-Kaplan ZA, Ozgu-Erdinc AS. Management of Gestational Diabetes Mellitus. Adv Exp Med Biol 2021;1307:257-72. [PMID: 32548833 DOI: 10.1007/5584_2020_552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
93 Jones M, Akers A. Update on Gestational Diabetes. Obesity and Diabetes 2020. [DOI: 10.1007/978-3-030-53370-0_36] [Reference Citation Analysis]
94 Mukerji G, Bacon S, Feig DS. Gestational Diabetes and Type 2 Diabetes During Pregnancy. Maternal-Fetal and Neonatal Endocrinology 2020. [DOI: 10.1016/b978-0-12-814823-5.00022-2] [Reference Citation Analysis]
95 Campbell IW. Metformin use in gestational diabetes. Obesity and Obstetrics 2020. [DOI: 10.1016/b978-0-12-817921-5.00018-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
96 Bishop KC, Harris BS, Boyd BK, Reiff ES, Brown L, Kuller JA. Pharmacologic Treatment of Diabetes in Pregnancy. Obstet Gynecol Surv 2019;74:289-97. [PMID: 31098642 DOI: 10.1097/OGX.0000000000000671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
97 Chen C, Huang Y, Dong G, Zeng Y, Zhou Z. The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review. Gynecol Endocrinol 2020;36:375-80. [PMID: 31858859 DOI: 10.1080/09513590.2019.1703943] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
98 Blair RA, Rosenberg EA, Palermo NE. The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy. Curr Diab Rep 2019;19:158. [PMID: 31811400 DOI: 10.1007/s11892-019-1243-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
99 Schäfer-graf U. Aktuell geltende Leitlinie Gestationsdiabetes. Diabetologe 2019;15:729-737. [DOI: 10.1007/s11428-019-00553-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Landi SN, Radke S, Engel SM, Boggess K, Stürmer T, Howe AS, Funk MJ. Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes. JAMA Pediatr 2019;173:160-8. [PMID: 30508164 DOI: 10.1001/jamapediatrics.2018.4214] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
101 Bianco ME, Josefson JL. Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes. Curr Diab Rep 2019;19:143. [PMID: 31754898 DOI: 10.1007/s11892-019-1267-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 11.8] [Reference Citation Analysis]
102 Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Bröms G, Einarsdóttir K, Furu K, Havard A, Heino A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Kieler H, Li J, Leinonen MK, Gulseth HL, Tran D, Yu Y, Zoega H, Odsbu I. Antidiabetic medication use during pregnancy: an international utilization study. BMJ Open Diabetes Res Care 2019;7:e000759. [PMID: 31798900 DOI: 10.1136/bmjdrc-2019-000759] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
103 Bao LX, Shi WT, Han YX. Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2021;34:2741-53. [PMID: 31558075 DOI: 10.1080/14767058.2019.1670804] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
104 Wexler DJ, Powe CE, Barbour LA, Buchanan T, Coustan DR, Corcoy R, Damm P, Dunne F, Feig DS, Ferrara A, Harper LM, Landon MB, Meltzer SJ, Metzger BE, Roeder H, Rowan JA, Sacks DA, Simmons D, Umans JG, Catalano PM. Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Obstet Gynecol 2018;132:496-505. [PMID: 29995731 DOI: 10.1097/AOG.0000000000002726] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 11.5] [Reference Citation Analysis]
105 Hu J, Zhang J, Zhu B. Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia. Fundam Clin Pharmacol 2019;33:649-58. [PMID: 31334867 DOI: 10.1111/fcp.12501] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
106 Bettencourt-Silva R, Neves JS, Ferreira MJ, Souteiro P, Belo S, Oliveira AI, Carvalho D, Namora G, Montenegro N, Queirós J. Metformin in overweight and obese women with gestational diabetes: a propensity score-matched study. Endocrine 2019;66:192-200. [PMID: 31401725 DOI: 10.1007/s12020-019-02043-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
107 Prentice PM, Olga L, Petry CJ, Simmons D, Murphy HR, Hughes IA, Acerini CL, Ong KK, Dunger DB. Reduced size at birth and persisting reductions in adiposity in recent, compared with earlier, cohorts of infants born to mothers with gestational diabetes mellitus. Diabetologia. 2019;62:1977-1987. [PMID: 31396660 DOI: 10.1007/s00125-019-4970-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
108 Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis. PLoS Med 2019;16:e1002848. [PMID: 31386659 DOI: 10.1371/journal.pmed.1002848] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 17.8] [Reference Citation Analysis]
109 Ringholm L, Damm P, Mathiesen ER. Improving pregnancy outcomes in women with diabetes mellitus: modern management. Nat Rev Endocrinol 2019;15:406-16. [PMID: 30948803 DOI: 10.1038/s41574-019-0197-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
110 McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5:47. [PMID: 31296866 DOI: 10.1038/s41572-019-0098-8] [Cited by in Crossref: 393] [Cited by in F6Publishing: 427] [Article Influence: 98.3] [Reference Citation Analysis]
111 Scavini M, Secchi A. Diabetes in pregnancy. Acta Diabetol 2019;56:719-21. [PMID: 31119458 DOI: 10.1007/s00592-019-01364-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
112 Rowan JA. Comment on Barbour and Feig. Metformin for Gestational Diabetes Mellitus: Progeny, Perspective, and a Personalized Approach. Diabetes Care 2019;42:396-399. Diabetes Care 2019;42:e130. [PMID: 31221714 DOI: 10.2337/dc19-0654] [Reference Citation Analysis]
113 Szmuilowicz ED, Josefson JL, Metzger BE. Gestational Diabetes Mellitus. Endocrinol Metab Clin North Am 2019;48:479-93. [PMID: 31345518 DOI: 10.1016/j.ecl.2019.05.001] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 18.8] [Reference Citation Analysis]
114 D'ambrosio V, Brunelli R, Vena F, Di Mascio D, Marchetti C, Boccherini C, Piccioni MG, Benedetti Panici P, Giancotti A. Metformin reduces maternal weight gain in obese pregnant women: A systematic review and meta‐analysis of two randomized controlled trials. Diabetes Metab Res Rev 2019;35. [DOI: 10.1002/dmrr.3164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
115 Mitric C, Desilets J, Brown RN. Recent advances in the antepartum management of diabetes. F1000Res 2019;8:F1000 Faculty Rev-622. [PMID: 31119029 DOI: 10.12688/f1000research.15795.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
116 de Brito Alves JL, de Oliveira Y, Carvalho NNC, Cavalcante RGS, Pereira Lira MM, Nascimento LCPD, Magnani M, Vidal H, Braga VA, de Souza EL. Gut microbiota and probiotic intervention as a promising therapeutic for pregnant women with cardiometabolic disorders: Present and future directions. Pharmacol Res 2019;145:104252. [PMID: 31054952 DOI: 10.1016/j.phrs.2019.104252] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
117 Garcia-Contreras C, Vazquez-Gomez M, Pesantez-Pacheco JL, Torres-Rovira L, Heras-Molina A, Encinas T, Astiz S, Gonzalez-Bulnes A. Maternal Metformin Treatment Improves Developmental and Metabolic Traits of IUGR Fetuses. Biomolecules 2019;9:E166. [PMID: 31035702 DOI: 10.3390/biom9050166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
118 Feghali MN, Umans JG, Catalano PM. Drugs to Control Diabetes During Pregnancy. Clin Perinatol 2019;46:257-72. [PMID: 31010559 DOI: 10.1016/j.clp.2019.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Xu Q, Xie Q. Long-term effects of prenatal exposure to metformin on the health of children based on follow-up studies of randomized controlled trials: a systematic review and meta-analysis. Arch Gynecol Obstet 2019;299:1295-303. [PMID: 30953188 DOI: 10.1007/s00404-019-05124-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
120 Barbour LA, Feig DS. Metformin for Gestational Diabetes Mellitus: Progeny, Perspective, and a Personalized Approach. Diabetes Care 2019;42:396-9. [PMID: 30787061 DOI: 10.2337/dci18-0055] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
121 Maple-Brown LJ, Lindenmayer G, Barzi F, Whitbread C, Connors C, Moore E, Boyle J, Kirkwood M, Lee IL, Longmore D, van Dokkum P, Wicks M, Dowden M, Inglis C, Cotter M, Kirkham R, Corpus S, Chitturi S, Thomas S, O'Dea K, Zimmet P, Oats J, McIntyre HD, Brown A, Shaw JE; Northern Territory Diabetes in Pregnancy Partnership. Real-world experience of metformin use in pregnancy: Observational data from the Northern Territory Diabetes in Pregnancy Clinical Register. J Diabetes 2019;11:761-70. [PMID: 30680949 DOI: 10.1111/1753-0407.12905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
122 Hanem LGE, Salvesen Ø, Juliusson PB, Carlsen SM, Nossum MCF, Vaage MØ, Ødegård R, Vanky E. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health 2019;3:166-74. [PMID: 30704873 DOI: 10.1016/S2352-4642(18)30385-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
123 Johns EC, Stoye DQ, Yang L, Reynolds RM. Influence of Maternal Obesity on the Long-Term Health of Offspring. Healthy Ageing and Longevity 2019. [DOI: 10.1007/978-3-030-24958-8_11] [Reference Citation Analysis]
124 Dodd JM, Louise J, Deussen AR, Grivell RM, Dekker G, Mcphee AJ, Hague W. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. The Lancet Diabetes & Endocrinology 2019;7:15-24. [DOI: 10.1016/s2213-8587(18)30310-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
125 American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42:S165-72. [PMID: 30559240 DOI: 10.2337/dc19-S014] [Cited by in Crossref: 182] [Cited by in F6Publishing: 190] [Article Influence: 36.4] [Reference Citation Analysis]
126 Garbarino VR, Santos TA, Nelson AR, Zhang WQ, Smolik CM, Javors MA, Daws LC, Gould GG. Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice. Pharmacol Res 2019;140:21-32. [PMID: 30423430 DOI: 10.1016/j.phrs.2018.11.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
127 Schäfer-Graf UM. Gestational Diabetes - Major New Clinically Relevant Aspects. Geburtshilfe Frauenheilkd 2018;78:977-83. [PMID: 30364451 DOI: 10.1055/a-0707-6697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
128 Barbour LA, Scifres C, Valent AM, Friedman JE, Buchanan TA, Coustan D, Aagaard K, Thornburg KL, Catalano PM, Galan HL, Hay WW Jr, Frias AE, Shankar K, Simmons RA, Moses RG, Sacks DA, Loeken MR. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 2018;219:367.e1-7. [PMID: 29959933 DOI: 10.1016/j.ajog.2018.06.013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
129 Finneran MM, Landon MB. Oral Agents for the Treatment of Gestational Diabetes. Curr Diab Rep 2018;18. [DOI: 10.1007/s11892-018-1093-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
130 Finneran MM, Landon MB. Oral Agents for the Treatment of Gestational Diabetes. Curr Diab Rep 2018;18:119. [PMID: 30267230 DOI: 10.1007/s11892-018-1093-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 2.6] [Reference Citation Analysis]
131 Stupin JH. Kernaspekte der aktualisierten S3-Leitlinie Gestationsdiabetes. Info Diabetol 2018;12:33-47. [DOI: 10.1007/s15034-018-1297-1] [Reference Citation Analysis]
132 Reynolds R, Gordon A. Obesity, fertility and pregnancy: Can we intervene to improve outcomes? J Endocrinol 2018:JOE-18-0199. [PMID: 30400070 DOI: 10.1530/JOE-18-0199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
133 van Weelden W, Wekker V, de Wit L, Limpens J, Ijäs H, van Wassenaer-Leemhuis AG, Roseboom TJ, van Rijn BB, DeVries JH, Painter RC. Long-Term Effects of Oral Antidiabetic Drugs During Pregnancy on Offspring: A Systematic Review and Meta-analysis of Follow-up Studies of RCTs. Diabetes Ther 2018;9:1811-29. [PMID: 30168045 DOI: 10.1007/s13300-018-0479-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
134 Nguyen L, Chan SY, Teo AKK. Metformin from mother to unborn child - Are there unwarranted effects? EBioMedicine. 2018;35:394-404. [PMID: 30166273 DOI: 10.1016/j.ebiom.2018.08.047] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
135 Patti AM, Giglio RV, Pafili K, Rizzo M, Papanas N. Pharmacotherapy for gestational diabetes. Expert Opin Pharmacother 2018;19:1407-14. [PMID: 30136869 DOI: 10.1080/14656566.2018.1509955] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
136 Vanky E, Ødegård R. Metformin in pregnancy - safe or sorry? Nat Rev Endocrinol 2018;14:570-2. [PMID: 30120391 DOI: 10.1038/s41574-018-0081-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
137 Zhen XM, Li X, Chen C. Longer-term outcomes in offspring of GDM mothers treated with metformin versus insulin. Diabetes Res Clin Pract 2018;144:82-92. [PMID: 30031048 DOI: 10.1016/j.diabres.2018.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
138 Paschou SA, Wolffenbuttel BHR. Metformin use during pregnancy: Is it really safe? J Diabetes 2018;10:984-5. [PMID: 29987873 DOI: 10.1111/1753-0407.12813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
139 Hyer S, Balani J, Shehata H. Metformin in Pregnancy: Mechanisms and Clinical Applications. Int J Mol Sci 2018;19:E1954. [PMID: 29973490 DOI: 10.3390/ijms19071954] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]